It looks like you're offline.
Open Library logo
additional options menu

MARC Record from harvard_bibliographic_metadata

Record ID harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:696634760:3921
Source harvard_bibliographic_metadata
Download Link /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:696634760:3921?format=raw

LEADER: 03921cam a22005177a 4500
001 011790479-1
005 20110311190659.0
008 080710s2008 enka b 001 0 eng
010 $a 2008932889
015 $aGBA921634$2bnb
016 7 $a101491358$2DNLM
016 7 $a014778956$2Uk
020 $a9781848440777
020 $a1848440774
035 0 $aocn246917440
040 $aNLM$cNLM$dYDXCP$dBTCTA$dBWX$dGUL$dPUL$dUKM$dNLA$dGEBAY$dDLC$dMH-L
042 $anlmcopyc$alccopycat
043 $ad------
050 00 $aRA643.86.D44$bP65 2008
060 00 $a2008 N-461
060 10 $aWC 503$bP7695 2008
082 04 $a362.19697920091724$222
245 04 $aThe political economy of HIV/AIDS in developing countries :$bTRIPS, public health systems, and free access /$cedited by Benjamin Coriat.
260 $aCheltenham, UK ;$aNorthampton, MA :$bEdward Elgar,$cc2008.
300 $axxii, 323 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references and index.
505 00 $tNew antiretroviral treatments and post-2005 TRIPS constraints : first moves toward IP flexibilization in developing countries /$rCristina d' Almeida ... [et al.] --$tNew trends in IP protection and health issues in FTA negotiations /$rGaëlle Krikorian --$tEvolution of prices and quantities of ARV drugs in African countries: from emerging to strategic markets /$rJulien Chauveau ... [et al.] --$tThe Brazilian experience of 'scaling-up' : a public policy approach /$rGuillaume Le Loup ... [et al.] --$tTechnology transfer agreements and access to HIV/AIDS drugs : the Brazilian case /$rAmélie Robine --$tScaling-up and reverse engineering : acquisition of industrial knowledge by copying drugs in Brazil /
505 00 $rMaurice Cassier and Marilena Correa --$tCompulsory licensing in the real world : the case of ARV drugs in Brazil /$rCristina de Albuquerque Possas --$tHIV prevalence estimates : the new deal in Sub-Saharan Africa since 2000 /$rJoseph Larmarange --$tCost-effectiveness of HIV antiretroviral therapies in resource-limited settings /$rYazdan Yazdanpanah, Caroline E. Sloan and Kenneth A. Freedberg --$t'Fragility' : a macro-dynamic motive to offer quick and general access to ART in LDC /$rBruno Ventelou, Yann Videau and Jean-Paul Moatti --$tProcurement policies, governance models and ARV availability in French-speaking African countries : an overview /$rMamadou Camara ... [et al.] --$tThe public health approach to antiretroviral treatment : the case of Cameroon /$rSinata Koulla-Shiro and Eric Delaporte --$tThe cost of universal free access for treating HIV/AIDS in low-income countries : the case of Senegal /
505 00 $rBernard Taverne, Karim Diop and Philippe Vinard --$tImplementing funding modalities for free access : the case for a 'purchasing fund system' to cover medical care for PLWHA /$rPhilippe Vinard, Karim Diop and Bernard Taverne.
651 7 $aEntwicklungsländer.$2swd
650 07 $aMedizinische Versorgung.$2swd
650 07 $aAIDS-Kranker.$2swd
630 07 $aÜbereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum.$2swd
630 00 $aAgreement on Trade-Related Aspects of Intellectual Property Rights$d(1994)
650 0 $aAIDS (Disease)$xEconomic aspects$zDeveloping countries.
650 0 $aPublic health$zDeveloping countries.
650 0 $aHealth services accessibility$zDeveloping countries.
630 02 $aAgreement on Trade-Related Aspects of Intellectual Property Rights$d(1994)
650 12 $aAcquired Immunodeficiency Syndrome$xeconomics$zDeveloping Countries.
650 22 $aAcquired Immunodeficiency Syndrome$xdrug therapy$zDeveloping Countries.
650 22 $aAnti-HIV Agents$xeconomics$zDeveloping Countries.
650 22 $aDrugs, Generic$xeconomics$zDeveloping Countries.
650 22 $aHealth Services Accessibility$xeconomics$zDeveloping Countries.
700 1 $aCoriat, Benjamin.
988 $a20081217
906 $0OCLC